Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involment

Hematology and Cell Therapy

Volumn 41, Issue 1, 1999, Pages 5-11

  Viret, F ^a,b   Blaise, D ^a   Bouabdallah, R ^a   Stoppa, A M ^a   Novakovitch, G ^a   Faucher, C ^a   Vey, N ^a   Camerlo, J ^a   Oziel Taieb, S ^a   Ladaique, P ^a   Gastaut, J A ^a   Maraninchi, D ^a   Chabannon, C ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Bone marrow transplantation; Chemotherapy; Non Hodgkin's lymphoma; Positive CD34 selection

Indexed keywords

BLEOMYCIN; CD34 ANTIGEN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERFERON; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; APHERESIS; ARTICLE; BONE MARROW METASTASIS; CELL SELECTION; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHATIC SYSTEM TUMOR; MALE; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; WHOLE BODY RADIATION;

EID: 0033025346     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-999-0005-y     Document Type: Article

References (34)

1. Armitage JO (1989) Bone marrow transplantation in the treatment of patients with lymphoma. Blood 7 : 1749-1758
2. Bensinger W, Appelbaum F, Rowley S, et al (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13: 2547-2555
3. Berenson RJ, Bensinger WI, Hill RS, et al (1991) Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77: 1717-1722
4. Bierman PJ, Vose JM, Anderson JR, et al (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 15: 445-450
5. Brenner MK, Hill DR, Holladay MS, et al (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342: 1134-1137
6. Chabannon C, Le Coroller AG, Faucher C, et al (1995) Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 4: 171-179
7. Chabannon C, Viens P, Camerlo J, et al (1996) A randomized study of peripheral blood stem cells or isolated CD34+ cells for hematologic rescue of advanced breast cancer patients treated with high-dose chemotherapy (abstract). Proc Am Ass Cancer Res 37: 176
8. Civin CI, Trischmann T, Kadan NS, et al (1996) Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 14: 2224-2233
9. Colombat P, Donadio P, Fouillard L, et al (1994) Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 13: 157-162
10. Cottler-Fox M, Cipolone K, Yu M, et al (1995) Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T-cell depletion equivalent to elutriation. Exp Hematol 23: 320-322
11. Dana BW, Dahlberg S, Nathwani BN, et al (1993) Long-term folluw-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 11: 644-651
12. Deisseroth AB, Zu Z, Claxton D, et al (1994) Genetic Marking Shows That Ph+ Cells Present in Autologous Transplants of Chronic Myelogenous Leukemia (CML) Contribute to Relapse After Autologous Bone Marrow in CML. Blood 83: 3068-3076
13. Faucher C, Le Corroller AG, Chabannon C, et al (1996) Autologous transplantation of blood stem cells mobilized with G-CSF alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery. J Hematother 5: 663-670
14. Freedman AS, Gribben JG, Neuberg D, et al (1996) High-Dose Therapy and Autologous Bone Marrow Transplantation in Patients With Follicular Lymphoma During First Remission. Blood 88: 2780-2786
15. Gallagher CJ, Gregory WM, Jones AE, et al (1986) Follicular lymphoma prognostics factors for response and survival. J Clin Oncol 4: 1470-1480
16. Gaspard MH, Maraninchi D, Stoppa AM, et al (1988) Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother Pharmacol 22: 256-262
17. Gorin NC, Lopez M, Laporte JP, et al (1995) Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 86: 1647-1654
18. Gratwohl A, Hermans J, Baldomero H (1996) Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 17: 137-148
19. Greaves MF, Titley I, Colman SM, et al (1995) CD34 cluster workshop report In: Schlossman SF, Boumsell L, Gilks W (eds) Leukocytes typing V. White cell differenciation antigens. Oxford University Press, Oxford. Vol One
20. Gribben JG, Freedman AS, Neuberg D, et al (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325: 1525-1533
21. Haas R, Möhle R, Frühauf S, et al (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83: 3787-3794
22. Hohaus S, Pförsich M, Murea S, et al (1997) Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer. Br J Haematol 97: 881-888
23. Lemoli RM, Fortuna A, Motta MR, et al (1996) Concomittant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 87: 1625-1634
24. Lopez M, Lemoine FM, Firat H, et al (1997) Bone marrow peripheral blood progenitor cells CD34 selection in patients with non-hodgkin's lymphomas: Different levels of tumor cell reduction. Implications for autografting. Blood 90: 2830-2838
25. Mahé B, Milpied N, Hermouet S, et al (1996) G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphoma. Br J Haematol 92: 263-268
26. Mapara M, Körner IJ, Hildebrandt M, et al (1997) Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89: 337-344
27. McQuaker IG, Haynes AP, Anderson S, et al (1997) Engraftment and molecular monitoring of CD34+ peripheral blood stem cell transplants for follicular lymphoma: a pilot study. J Clin Oncol 15: 2288-2295
28. Philip T, Armitage JO, Spitzer JO, et al (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non Hodgkin's lymphoma. New Engl J Med 316: 1493-1498
29. Rill DR, Santana VM, Roberts WM, et al (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicicity of tumorigenic cells. Blood 84: 380-383
30. Rohatiner A, Lister A (1994) Management of follicular lymphoma. Curr Opin Oncol 6: 473-479
31. Schiller G, Vescio R, Freytes C, et al (1995) Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 96: 390-397
32. Shpall E, Jones R, Bearman SI, et al (1994) Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12: 28-36
33. Takvorian T, Canellos GP, Ritz J, et al (1987) Prolonged disease free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. New Engl J Med 316: 1499-1505
34. Weaver C, Hazelton B, Birch R, et al (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86: 3961-3969